Efficacy and tolerability of agomelatine in generalized anxiety disorder (gad) : A randomised double-blind, placebo-controlled trial with escitalopram as validator

被引：0
|
作者：
Stein, D. [1 ]
Marquez, M. S. [1 ]
Hoeschl, C. [1 ]
Ahokas, A. [1 ]
Oh, K. S. [1 ]
Jarema, M. [1 ]
Avedisova, A. [1 ]
Vavrusova, L. [1 ]
Olivier, V. [1 ]
机构：
[1] Univ Cape Town, Dept Psychiat, Cape Town, South Africa
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-04-019
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [41] Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH
    Denis, L
    Pagano, F
    Nonis, A
    Robertson, C
    Romano, P
    Boyle, P
    PROSTATE, 1998, 37 (04): : 246 - 252
  • [42] Efficacy and tolerability of escitalopram as monotherapy or in combination with mirtazapine in generalized anxiety disorder (GAD)
    Sulejmanpasic-Arslanagic, G.
    Fisekovic, S.
    Ler, S.
    Frenjo, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S507 - S508
  • [43] A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder
    Mahableshwarkar, A. R.
    Jacobsen, P. L.
    Chen, Y.
    Simon, J. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (01) : 49 - 59
  • [44] Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Rickels, Karl
    Athanasiou, Maria
    Robinson, Donald S.
    Gibertini, Michael
    Whalen, Heidi
    Reed, Carol R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 326 - 333
  • [45] Sertraline treatment for generalized anxiety disorder: A randomized, double-blind, placebo-controlled study
    Brawman-Mintzer, Olga
    Knapp, Rebecca G.
    Rynn, Moira
    Carter, Rickey E.
    Rickels, Karl
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (06) : 874 - 881
  • [46] Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial
    Farnia, Vahid
    Gharehbaghi, Haniyeh
    Alikhani, Mostafa
    Almasi, Afshin
    Golshani, Sanobar
    Tatari, Faeze
    Davarinejad, Omran
    Salemi, Safora
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 137 - 143
  • [47] A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder
    Bonne, O
    Shemer, Y
    Hom, RC
    Gorali, Y
    Katz, M
    Shalev, AY
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (03) : 282 - 287
  • [48] Kava in the Treatment of Generalized Anxiety Disorder A Double-Blind, Randomized, Placebo-Controlled Study
    Sarris, Jerome
    Stough, Con
    Bousman, Chad A.
    Wahid, Zahra T.
    Murray, Greg
    Teschke, Rolf
    Savage, Karen M.
    Dowell, Ashley
    Ng, Chee
    Schweitzer, Isaac
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (05) : 643 - 648
  • [49] Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study
    Schutters, Sara I. J.
    Van Megen, Harold J. G. M.
    Van Veen, Jantien Frederieke
    Denys, Damiaan A. J. P.
    Westenberg, Herman G. M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (05) : 302 - 304
  • [50] Ziprasidone Treatment of Refractory Generalized Anxiety Disorder A Placebo-Controlled, Double-Blind Study
    Lohoff, Falk W.
    Etemad, Bijan
    Mandos, Laura A.
    Gallop, Robert
    Rickels, Karl
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 185 - 189
12345